The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria

W. H. Boehncke; R. J. Ludwig; T. M. Zollner; F. Ochsendorf; R. Kaufmann; B. F. Gibbs

doi:10.1046/j.1365-2133.2003.05209_12.x

The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria

W. H. Boehncke^*, R. J. Ludwig, T. M. Zollner, F. Ochsendorf, R. Kaufmann, B. F. Gibbs

^*Corresponding author for this work

Clinic of Dermatology, Allergology and Venerology

Johann Wolfgang Goethe-University

13 Citations (Scopus)

Original language	English
Journal	British Journal of Dermatology
Volume	148
Issue number	3
Pages (from-to)	604-606
Number of pages	3
ISSN	0007-0963
DOIs	https://doi.org/10.1046/j.1365-2133.2003.05209_12.x
Publication status	Published - 01.03.2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1046/j.1365-2133.2003.05209_12.x

Cite this

@article{aeb6b2170b0b4fd782131a2e428e9ece,

title = "The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria",

author = "Boehncke, {W. H.} and Ludwig, {R. J.} and Zollner, {T. M.} and F. Ochsendorf and R. Kaufmann and Gibbs, {B. F.}",

year = "2003",

month = mar,

day = "1",

doi = "10.1046/j.1365-2133.2003.05209_12.x",

language = "English",

volume = "148",

pages = "604--606",

journal = "British Journal of Dermatology",

issn = "0007-0963",

number = "3",

}

TY - JOUR

T1 - The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria

AU - Boehncke, W. H.

AU - Ludwig, R. J.

AU - Zollner, T. M.

AU - Ochsendorf, F.

AU - Kaufmann, R.

AU - Gibbs, B. F.

PY - 2003/3/1

Y1 - 2003/3/1

UR - http://www.scopus.com/inward/record.url?scp=0037365401&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2133.2003.05209_12.x

DO - 10.1046/j.1365-2133.2003.05209_12.x

M3 - Letters

C2 - 12653769

AN - SCOPUS:0037365401

SN - 0007-0963

VL - 148

SP - 604

EP - 606

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria

UN SDGs

Access to Document

Other files and links

Cite this